Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2018-08-13 History
Report ID 50678
Drug Identification Number 02299631
Brand name PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
Common or Proper name PIPERACILLIN-TAZOBACTAM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 3G 0.375G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-25
Estimated end date 2018-07-13
Actual end date 2018-07-13
Shortage status Resolved
Updated date 2018-08-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-08-13 French Compare
v5 2018-08-13 English Compare
v4 2018-07-03 French Compare
v3 2018-07-03 English Compare
v2 2018-05-29 French Compare
v1 2018-05-29 English Compare

Showing 1 to 6 of 6